Higashi Y, Bello-Reuss E
Kidney Int. 1980 Sep;18(3):302-8. doi: 10.1038/ki.1980.140.
The renal effects of sodium vanadate (Na3VO4), an inhibitor of sodium-potassium-ATPase recently shown to be a potent diuretic, were studied by using clearance and micropuncture techniques in nondiuretic anesthetized rats. Administration of 1.0 mumole of sodium vanadate (high dose) increased urine flow rate (V) from 9.8 +/- 1.4 to 17.5 +/- 4.0 microliter/min (mean +/- SEM, P < 0.025), UNaF from 1.73 +/- 0.36 to 3.05 +/- 0.65 microEq/min (P < 0.025), and FENa from 0.67 +/- 0.15 to 1.24 +/- 0.28% (P < 0.025)., No significant changes in GFR or RPF were observed. Late proximal tubular-fluid-to-plasma (F/P) inulin decreased from 2.28 +/- 0.19 to a minimum value of 1.38 +/- 0.06 (P < 0.025). Absolute water reabsorption decreased from 15.8 +/- 3.5 to 6.5 +/- 1.7 nl/min (P < 0.025) and fractional water reabsorption from 52.0 +/- 4.4 to 26.5 +/- 4.1% (P < 0.025). The injection of 0.5 mumole of sodium vanadate (low dose) resulted in no significant changes in V. Late proximal F/P inulin decreased, however, from 2.37 +/- 0.14 to a minimum value of 1.59 +/- 0.12 (P < 0.025). SNGFR remained unchanged, as did GFR and RPF. UNaV increased from 1.41 +/- 0.35 to 2.25 +/- 0.35 microEq/min (P < 0.025), and FENa rose from 0.64 +/- 0.16 to 0.91 +/- 0.15% (P < 0.025). The decrease in F/P inulin was observed in all but one animal, even in the absence of a diuretic response. The amount of fluid remaining in the lumen of the late proximal tubule was virtually the same in both low- and high-dose animals (18.9 +/- 3.0 and 19.5 +/- 3.4 nl/min, respectively). We conclude that sodium vanadate causes a decrease in superficial proximal tubule fluid and salt reabsorption. Inasmuch as the low dose does not result necessarily in a diuretic response, an increase in fluid reabsorption distal to the late proximal tubule must take place.
钒酸钠(Na3VO4)是一种钠钾ATP酶抑制剂,最近被证明是一种强效利尿剂,本研究采用清除率和微穿刺技术,在非利尿麻醉大鼠中研究了其对肾脏的影响。给予1.0微摩尔钒酸钠(高剂量)可使尿流率(V)从9.8±1.4微升/分钟增加至17.5±4.0微升/分钟(平均值±标准误,P<0.025),尿钠排泄分数(UNaF)从1.73±0.36微当量/分钟增加至3.05±0.65微当量/分钟(P<0.025),滤过钠排泄分数(FENa)从0.67±0.15%增加至1.24±0.28%(P<0.025)。肾小球滤过率(GFR)或肾血浆流量(RPF)未观察到显著变化。近端小管晚期管腔液与血浆(F/P)菊粉比值从2.28±0.19降至最低值1.38±0.06(P<0.025)。绝对水重吸收从15.8±3.5纳升/分钟降至6.5±1.7纳升/分钟(P<0.025),水重吸收分数从52.0±4.4%降至26.5±4.1%(P<0.025)。注射0.5微摩尔钒酸钠(低剂量)导致V无显著变化。然而,近端小管晚期F/P菊粉比值从2.37±0.14降至最低值1.59±0.12(P<0.025)。单个肾单位肾小球滤过率(SNGFR)保持不变,GFR和RPF也如此。UNaV从1.41±0.35微当量/分钟增加至2.25±0.35微当量/分钟(P<0.025),FENa从0.64±0.16%升至0.91±0.15%(P<0.025)。除一只动物外,在所有动物中均观察到F/P菊粉比值降低,即使在无利尿反应的情况下也是如此。低剂量和高剂量动物近端小管晚期管腔内剩余的液体量几乎相同(分别为18.9±3.0和19.5±3.4纳升/分钟)。我们得出结论,钒酸钠可导致浅表近端小管液和盐重吸收减少。由于低剂量不一定导致利尿反应,近端小管晚期远端的液体重吸收必然增加。